home / stock / evax / evax short
Short Information | Evaxion Biotech A/S (NASDAQ:EVAX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 221,868 |
Total Actual Volume | 1,066,034 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 11,093 |
Average Short Percentage | 16.48% |
Is there a EVAX Short Squeeze or Breakout about to happen?
See the EVAX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-24-2024 | $4.18 | $4.13 | $4.18 | $4.05 | 10,156 | 480 | 4.73% |
04-23-2024 | $4.28 | $4.14 | $4.28 | $3.99 | 25,022 | 2,020 | 8.07% |
04-22-2024 | $4.36 | $4.19 | $4.36 | $4.19 | 9,891 | 760 | 7.68% |
04-19-2024 | $4.24 | $4.31 | $4.4095 | $4.1701 | 30,943 | 10,029 | 32.41% |
04-18-2024 | $4.11 | $4.22 | $4.2482 | $4.11 | 35,375 | 7,482 | 21.15% |
04-17-2024 | $4.1 | $4.11 | $4.15 | $3.93 | 29,921 | 8,016 | 26.79% |
04-16-2024 | $4 | $4.04 | $4.11 | $3.9 | 25,139 | 2,324 | 9.24% |
04-15-2024 | $3.98 | $4.1 | $4.19 | $3.8574 | 44,816 | 1,973 | 4.4% |
04-12-2024 | $3.8 | $4.1 | $4.13 | $3.8 | 30,866 | 8,584 | 27.81% |
04-11-2024 | $4 | $3.89 | $4 | $3.52 | 34,247 | 1,941 | 5.67% |
04-10-2024 | $4.17 | $3.99 | $4.17 | $3.84 | 38,481 | 2,139 | 5.56% |
04-09-2024 | $4 | $3.96 | $4.1099 | $3.85 | 36,207 | 5,230 | 14.44% |
04-08-2024 | $3.7 | $4.09 | $4.11 | $3.7 | 88,525 | 22,511 | 25.43% |
04-05-2024 | $3.65 | $3.69 | $3.85 | $3.59 | 45,188 | 9,710 | 21.49% |
04-04-2024 | $3.71 | $3.65 | $3.8458 | $3.65 | 41,978 | 5,296 | 12.62% |
04-03-2024 | $3.88 | $3.6 | $4.199 | $3.48 | 162,486 | 29,379 | 18.08% |
04-02-2024 | $3.4 | $3.88 | $3.9 | $3.15 | 310,637 | 92,831 | 29.88% |
04-01-2024 | $3.2 | $3.23 | $3.4464 | $3.08 | 23,332 | 2,660 | 11.4% |
03-28-2024 | $3 | $3.2 | $3.2 | $3 | 17,197 | 4,972 | 28.91% |
03-27-2024 | $3.13 | $3 | $3.13 | $2.9 | 25,627 | 3,531 | 13.78% |
News, Short Squeeze, Breakout and More Instantly...
Evaxion Biotech A/S Company Name:
EVAX Stock Symbol:
NASDAQ Market:
Significant Phase 2 clinical trial progress obtained with first patient finalizing EVX-01 vaccine dosing Favorable safety profile confirmed Trial on track for one-year clinical efficacy readout in Q3 2024 COPENHAGEN, Denmark, April 17, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S ...
Evaxion and its collaborator tested Evaxion-designed vaccine antigens against Staphylococcus aureus in a clinically relevant animal model of surgical site infections The vaccine antigens significantly protected large, non-rodent animals against surgical site infections, indicating promisi...
Precision vaccine project initiated with the ambition to obtain Preclinical Proof-of-Concept by H2 2024. The novel concept entails AI-identification of a new class of cancer vaccine targets, named endogenous retroviruses (ERVs), broadening the potential of cancer vaccines. Successful completi...